Immunomodulators (IMDs) Today

A panel of experts discuss the bedrock therapy in multiple myeloma immunomodulators (IMDs). The panel includes: Jenny Ahlstrom – Founder and Chief Executive Officer, Healthtree Foundation Diane Moran – Business…

Tailored Multiple Myeloma Care

A panel of experts discuss strategies for how to best support multiple myeloma patients and their families during treatment. The panel includes: Diane Moran – Business Relationship Management, International Myeloma…

Can Self-Advocacy Close the Gap in Bladder Cancer Outcomes?

https://vimeo.com/1062233283 Bladder cancer research insights show disparities for specific groups. Expert Dr. Shaakir Hasan from Beth Israel Lahey Health discusses highlights from his research study, the value of seeking medical attention and…

When Is Immunotherapy Recommended in Bladder Cancer?

https://vimeo.com/1060749973 Bladder cancer immunotherapy is available, but which patients qualify for it? Expert Dr. Shaakir Hasan from Beth Israel Lahey Health discusses who is eligible for immunotherapy, patient factors that contraindicate against…

Bladder Cancer Awareness: The Power of Early Detection

https://vimeo.com/1059926456 What impact can early detection have on bladder cancer? Expert Dr. Shaakir Hasan from Beth Israel Lahey Health discusses the difference that early detection can make on bladder cancer prognosis, common…

Multiple Myeloma Community Barriers

A panel of experts discuss the barriers multiple myeloma patients face when receiving care in community-based settings. The panel includes: Jenny Ahlstrom – Founder and Chief Executive Officer, Healthtree Foundation…

Share On:

Facebook
Twitter
LinkedIn